4.4 Article

Reduced oxygen stress promotes propagation of murine postnatal enteric neural progenitors in vitro

Journal

NEUROGASTROENTEROLOGY AND MOTILITY
Volume 23, Issue 10, Pages E412-E424

Publisher

WILEY-BLACKWELL
DOI: 10.1111/j.1365-2982.2011.01761.x

Keywords

Anti-oxidants; enteric neural progenitors; enteric nervous system; gut; hypoxia; oxygen

Funding

  1. German Federal Ministry of Education and Research (BMBF) [0313909]

Ask authors/readers for more resources

Background Neural stem and progenitor cells of the Enteric Nervous System (ENS) are regarded as a novel cell source for applications in regenerative medicine. However, improvements to the current ENS cell culture protocols will be necessary to generate clinically useful cell numbers under defined culture conditions. Beneficial effects of physiologically low oxygen concentrations and/or the addition of anti-oxidants on propagation of various types of stem cells have previously been demonstrated. In this study, we tested the effects of such culture conditions on ENS stem and progenitor cell behavior. Methods Enteric neural progenitor cells were isolated from postnatal day 3 mouse intestine and propagated either as monolayers or neurosphere-like bodies. The influence of hypoxic culture conditions and/or anti-oxidants on enteric cell propagation were studied systematically using proliferation, differentiation and apoptosis assays, whereas effects on gene expression were determined by qRT-PCR, western blot, and immunocytochemistry. Key Results Both hypoxic culture conditions and antioxidants supported a significantly improved enteric cell propagation and the generation of differentiated neural cell types. Enteric neural progenitors were shown to be specifically vulnerable to persistent oxidative stress. Conclusions & Inferences Our findings are consistent with previous reports of improved maintenance of brain stem cells cultured under reduced oxygen stress conditions and may therefore be applied to future cell culture protocols in ENS stem cell research.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biophysics

Clinical impact of clonal hematopoiesis in acute myeloid leukemia patients receiving allogeneic transplantation

Juliane Grimm, Marius Bill, Madlen Jentzsch, Stefanie Beinicke, Janine Haentschel, Karoline Goldmann, Julia Schulz, Michael Cross, Georg-Nikolaus Franke, Gerhard Behre, Vladan Vucinic, Wolfram Poenisch, Thoralf Lange, Dietger Niederwieser, Sebastian Schwind

BONE MARROW TRANSPLANTATION (2019)

Article Pathology

Comparison of Real-Time Quantitative PCR and Digital Droplet PCR for BCR-ABL1 Monitoring in Patients with Chronic Myeloid Leukemia

Georg-Nikolaus Franke, Jacqueline Maier, Kathrin Wildenberger, Michael Cross, Francis J. Giles, Martin C. Mueller, Andreas Hochhaus, Dietger Niederwieser, Thoralf Lange

JOURNAL OF MOLECULAR DIAGNOSTICS (2020)

Article Oncology

No advantage of Imatinib in combination with hydroxyurea over Imatinib monotherapy: a study of the East German Study Group (OSHO) and the German CML study group

Thoralf Lange, Christian Niederwieser, Arthur Gil, Rainer Krahl, Ulrich von Gruenhagen, Haifa Kathrin Al-Ali, Kathleen Jentsch-Ullrich, Claudia Spohn, Volker Lakner, Michael Assmann, Christian Junghanss, Michael Cross, Ruediger Hehlmann, Michael Deininger, Markus Pfirrmann, Dietger Niederwieser

LEUKEMIA & LYMPHOMA (2020)

Review Biochemistry & Molecular Biology

Iron overload and its impact on outcome of patients with hematological diseases

Georg-Nikolaus Franke, Anne Sophie Kubasch, Michael Cross, Vladan Vucinic, Uwe Platzbecker

MOLECULAR ASPECTS OF MEDICINE (2020)

Article Oncology

Case Report: Allogeneic Stem Cell Transplantation Following Induction With CPX-351 in Patients With Acute Myeloid Leukemia Is Feasible

Vladan Vucinic, Madlen Jentzsch, Sebastian Schwind, Enrica Bach, Sabine Leiblein, Yvonne Remane, Susanne Rieprecht, Sandra Otto, Anne-Sophie Kubasch, Gerhard Behre, Michael Cross, Uwe Platzbecker, Georg-Nikolaus Franke

FRONTIERS IN ONCOLOGY (2020)

Article Oncology

Luspatercept restores SDF-1-mediated hematopoietic support by MDS-derived mesenchymal stromal cells

Manja Wobus, Anna Mies, Nandini Asokan, Uta Oelschlaegel, Kristin Moebus, Susann Winter, Michael Cross, Heike Weidner, Martina Rauner, Lorenz C. Hofbauer, Martin Bornhaeuser, Uwe Platzbecker

Summary: This study shows that luspatercept can restore ineffective hematopoiesis in MDS patients by modulating the functional properties of MSCs in the bone marrow microenvironment.

LEUKEMIA (2021)

Article Hematology

Allogeneic hematopoietic stem cell transplantation improves long-term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials

Thomas Heinicke, Rainer Krahl, Christoph Kahl, Michael Cross, Sebastian Scholl, Hans-Heinrich Wolf, Detlev Haehling, Ute Hegenbart, Norma Peter, Antje Schulze, Axel Florschuetz, Schmidt Volker, Kolja Reifenrath, Niklas Zojer, Christian Junghanss, Herbert G. Sayer, Georg Maschmeyer, Spath Christian, Andreas Hochhaus, Thomas Fischer, Haifa Kathrin Al-Ali, Dietger Niederwieser

Summary: Relapse of acute leukemia is a common complication with uncertain outcomes, affecting both younger and older patients. Factors such as hematopoietic cell transplantation and long-term remission are beneficial, while challenges remain in the treatment and prognosis of relapse.

ANNALS OF HEMATOLOGY (2021)

Correction Hematology

Allogeneic hematopoietic stem cell transplantation improves long-term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials (vol 100, pg 1181, 2021)

Thomas Heinicke, Rainer Krahl, Christoph Kahl, Michael Cross, Sebastian Scholl, Hans-Heinrich Wolf, Detlev Haehling, Ute Hegenbart, Norma Peter, Antje Schulze, Axel Florschuetz, Volker Schmidt, Kolja Reifenrath, Niklas Zojer, Christian Junghanss, Herbert G. Sayer, Georg Maschmeyer, Christian Spaeth, Andreas Hochhaus, Thomas Fischer, Haifa Kathrin Al-Ali, Dietger Niederwieser

ANNALS OF HEMATOLOGY (2021)

Article Oncology

Salvage Therapy With Polatuzumab Vedotin, Bendamustine, and Rituximab Prior to Allogeneic Hematopoietic Transplantation in Patients With Aggressive Lymphomas Relapsing After Therapy With Chimeric Antigen Receptor T-Cells-Report on Two Cases

Kristin Gerhardt, Madlen Jentzsch, Thomas Georgi, Aleksandra Sretenovi, Michael Cross, Enrica Bach, Astrid Monecke, Sabine Leiblein, Sandra Hoffmann, Milena Todorovi, Jelena Bila, Osama Sabri, Sebastian Schwind, Georg-Nikolaus Franke, Uwe Platzbecker, Vladan Vucinic

Summary: The study reports two heavily pretreated patients with different types of lymphoma who relapsed after CAR T-cell therapy and achieved complete metabolic remission after Pola-BR therapy, followed by alloHSCT treatment and disease-free survival post-operation. The findings suggest that Pola-BR may be an effective bridging therapy before alloHSCT for patients relapsing after CAR T-cell therapy.

FRONTIERS IN ONCOLOGY (2021)

Article Hematology

Stem-cell mobilization of healthy sibling donors with pegfilgrastim-A prospective open-label phase II trial (EudraCT no: 2005-004971-39)

Vladan Vucinic, Madlen Jentzsch, Sabine Leiblein, Enrica Bach, Yvonne Remane, Kai Schulze-Forster, Michael Cross, Wolfram Poenisch, Sebastian Schwind, Georg-Nikolaus Franke, Uwe Platzbecker, Dietger Niederwieser

Summary: The study found that stem cell mobilization with pegfilgrastim is a feasible and attractive option. Among the 28 related donors examined, 75% had a CD34+ count >50 cells/mu l on day four, and 89% of donors had CD34+ yields >= 4 x 10/kg body weight of the recipient. All grafts were administered without rejections.

TRANSFUSION (2022)

Review Cell Biology

How Azanucleosides Affect Myeloid Cell Fate

Anna Stein, Uwe Platzbecker, Michael Cross

Summary: This article examines the different mechanisms of action of azanucleosides in the treatment of myeloid neoplasia and their impact on stem cell lineage commitment and neoplastic progression. It also discusses the efficacy of azanucleoside treatment in neoplasias without mutations in epigenetic regulators. Furthermore, the article summarizes recent data on the role of azacytidine-sensitive RNA methylation in lineage commitment and cellular response to stress.

CELLS (2022)

Article Biochemistry & Molecular Biology

Clonal Hematopoiesis Mutations Are Present in Atherosclerotic Lesions in Peripheral Artery Disease

Petra Buettner, Julia Boettner, Knut Krohn, Ronny Baber, Uwe Platzbecker, Michael Cross, Steffen Desch, Holger Thiele, Sabine Steiner, Dierk Scheinert, Klaus H. Metzeler, Daniela Branzan

Summary: In this pilot study, it was found that clonal hematopoiesis (CH)-associated mutations can be detected in both peripheral blood cells and tissues associated with atherosclerosis, suggesting a potential impact on disease physiology.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Hematology

Reduction of Graft-versus-Host-Disease in NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ (NSG) Mice by Cotransplantation of Syngeneic Human Umbilical Cord-Derived Mesenchymal Stromal Cells

Max Hansen, Lilly Stahl, Andreas Heider, Nadja Hilger, Ulrich Sack, Andreas Kirschner, Michael Cross, Stephan Fricke

Summary: This study analyzed the potential beneficial effects of syngeneic versus allogenic treatment, culture expansion of MSCs, and various MSC cell doses and time points of MSC transplantation in a murine GVHD model. The results showed that syngeneic treatment, culture-expanded cells, simultaneous administration, and high doses of UC-MSCs were more effective in reducing CD8(+) T cells, protecting mice from weight loss, and prolonging survival. This animal model of GVHD can be used for further detailed studies on the efficacy of MSCs from alternative sources.

TRANSPLANTATION AND CELLULAR THERAPY (2021)

Article Cell & Tissue Engineering

Nicotinamide Inhibits Self-renewal and Induces Granulocyte Differentiation of Multipotent Progenitor Cells

Waseem Nasr, Claire Fabian, Katrin Arnold, Ulrike Koehl, Ulrich Sack, Ronald Weiss, Michael Cross, Sunna Hauschildt

STEM CELL REVIEWS AND REPORTS (2020)

Article Hematology

Prognostic Impact of Blood MN1 Copy Numbers Before Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia

Madlen Jentzsch, Marius Bill, Juliane Grimm, Julia Schulz, Stefanie Beinicke, Janine Haentschel, Karoline Goldmann, Wolfram Poenisch, Georg-Nikolaus Franke, Vladan Vucinic, Michael Cross, Gerhard Behre, Thoralf Lange, Dietger Niederwieser, Sebastian Schwind

HEMASPHERE (2019)

No Data Available